Leveraging sensor-based functional outcomes to enhance understanding of the patient experience: challenges and opportunities [0.03%]
基于传感器的功能预后结果在增强患者体验理解方面的挑战与机遇
Katelyn R Keyloun,Jessica Abel,Julia K Garcia et al.
Katelyn R Keyloun et al.
Introduction: Sensor-based digital health technology (DHT) has emerged as a promising means to assess patient functioning within and outside clinical trials. Sensor-based functional outcomes (SBFOs) provide valuable insig...
The implications of cardiac device cybersecurity responsibilities and challenges faced by policymakers, manufacturers, and patients [0.03%]
心脏设备网络安全的内涵及政策制定者、制造商和患者面临的问题与挑战
Bhakti Patel,Amgad N Makaryus
Bhakti Patel
Introduction: As digital health expands, reliance on digital endpoints is rapidly increasing to improve diagnostic accuracy and management in the healthcare field. Digital endpoints are beneficial to monitor how patient's...
Video-based assessments of activities of daily living: generating real-world evidence in pediatric rare diseases [0.03%]
基于视频的评估日常活动能力：在儿科罕见病中生成真实世界证据
Elisa Ferrer-Mallol,Clare Matthews,Rabia Aziza et al.
Elisa Ferrer-Mallol et al.
Introduction: Preserving function and independence to perform activities of daily living (ADL) is critical for patients and carers to manage the burden of care and improve quality of life. In children living with rare dis...
Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore [0.03%]
阿特珠单抗联合贝伐珠单抗与索拉非尼作为晚期肝细胞癌一线治疗的 cost-effectiveness 分析——基于新加坡地区研究数据
Cheng Ean Chee,Jasmeet Singh Khara,John Cheong et al.
Cheng Ean Chee et al.
Objectives: This study aims to explore the cost-effectiveness of atezolizumab plus bevacizumab against sorafenib for first-line treatment of locally advanced or metastatic hepatocellular carcinoma (HCC) in Singapore. ...
Unlocking the full potential of digital endpoints for decision making: a novel modular evidence concept enabling re-use and advancing collaboration [0.03%]
解锁数字终端的全部潜力以做出决策：一种新型模块化证据概念，实现重复使用和促进协作
Lada Leyens,John Batchelor,Erwin De Beuckelaer et al.
Lada Leyens et al.
Introduction: Over the last decade increasing examples indicate opportunities to measure patient functioning and its relevance for clinical and regulatory decision making via endpoints collected through digital health tec...
Quality-adjusted life years for HER2-positive, early-stage breast cancer using trastuzumab-containing regimens in the context of cost-effectiveness studies: a systematic review [0.03%]
赫珠单抗治疗HER2阳性早期乳腺癌质量调整生命年的系统性评审：成本效益研究中的应用
Sudewi Mukaromah Khoirunnisa,Fithria Dyah Ayu Suryanegara,Didik Setiawan et al.
Sudewi Mukaromah Khoirunnisa et al.
Introduction: This study aims to provide a comprehensive assessment of economic and health-related quality of life (HRQoL) outcomes for human epidermal growth factor receptor 2 (HER2)-positive, early-stage breast cancer p...
Economic evaluation of stereotactic radiotherapy and stereotactic radiosurgery technologies in the treatment of cancers: a systematic review [0.03%]
立体定向放射治疗和立体定向放射手术技术用于癌症治疗的经济评价：一项系统综述
Aziz Rezapour,Hanie Gholampour,Mohammad Barzegar et al.
Aziz Rezapour et al.
Introduction: This systematic review study investigated the cost-effectiveness of stereotactic radiotherapy (SRT) and stereotactic radiosurgery (SRS) for treatment of various types of cancers. ...
A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe [0.03%]
津巴布韦三级医院简化HCV筛查和治疗模型的成本分析
Blessing Dzingirai,Leolin Katsidzira,Vongai Mwanesani et al.
Blessing Dzingirai et al.
Background: The treatment of chronic hepatitis C virus (HCV) infection using directly acting antivirals was recently adopted in the treatment guidelines of Zimbabwe. The objectives of this study were to design a simplifie...
A Retrospective Budget Impact Analysis of Fidaxomicin Treatment for Clostridioides difficile Infections (CDI) in Germany [0.03%]
德国 fidaxomicin治疗艰难梭菌感染（CDI）的回顾性预算影响分析
Ann-Cathrine Siefen,Melina Sophie Kurte,Anna Marie Bauer et al.
Ann-Cathrine Siefen et al.
Background: Clostridioides difficile is the most common cause of healthcare-associated diarrhea. Research suggests that treating C. difficile infections (CDI) with fidaxomicin (FDX) is more effective than vancomycin (VAN)...
Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies [0.03%]
用药经济研究在阿片类药物使用障碍的循证医学中的作用
Ali Jalali
Ali Jalali
Introduction: The health and economic consequences of inadequately treated opioid use disorder (OUD) are substantial. Healthcare systems in the United States (US) and other countries are facing a growing healthcare crisis...